CALB2 negatively correlated with the critical steps of the cancer-immunity cycle, including priming and activation (Step 3), trafficking of immune cells to tumors (Step 4), infiltration of immune cells into tumors (Step 5), recognition of cancer cells by T cells (Step 6), and killing of cancer cells (Step 7) (Fig. S3C). This evidence concerns the gene CALB2 and cancer.